Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro

Clin Exp Pharmacol Physiol. 1995 May;22(5):381-2. doi: 10.1111/j.1440-1681.1995.tb02025.x.

Abstract

1. Inhibitors of nitric oxide (NO) formation or ADP-ribosylation attenuate methamphetamine (METH)- and methylenedioxymetamphetamine (MDMA)-induced neurotoxicity on dopaminergic and serotonergic cells in primary cultures. 2. They also prevent METH-induced reactive gliosis in dopaminergic cultures. 3. Overexpression of superoxide dismutase (SOD) in cells obtained from SOD-transgenic mice also attenuates drug-induced toxicity. 4. These data indicate a role for oxygen-based and NO free radicals in the mechanisms of cell death associated with drugs of abuse in vitro.

MeSH terms

  • Adenosine Diphosphate Ribose / antagonists & inhibitors
  • Adenosine Diphosphate Ribose / metabolism*
  • Animals
  • Arginine / metabolism*
  • Brain / cytology
  • Brain / drug effects
  • Brain / embryology
  • Cell Death / drug effects
  • Cells, Cultured
  • Dopamine / metabolism
  • Dopamine Agents / toxicity
  • Female
  • Free Radicals
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Gliosis / prevention & control
  • Illicit Drugs / toxicity*
  • Methamphetamine / toxicity
  • Mice
  • Mice, Transgenic
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism*
  • Oxidative Stress / physiology*
  • Pregnancy
  • Serotonin / metabolism
  • Serotonin Agents / toxicity
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism

Substances

  • Dopamine Agents
  • Free Radicals
  • Illicit Drugs
  • Serotonin Agents
  • Adenosine Diphosphate Ribose
  • Nitric Oxide
  • Serotonin
  • Methamphetamine
  • Arginine
  • Superoxide Dismutase
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Dopamine